Gabelli Funds LLC Sells 42,000 Shares of Tenet Healthcare Corporation $THC

Key Points

• Gabelli Funds LLC cut its stake in Tenet Healthcare by 30.6%, selling 42,000 shares and leaving 95,435 shares (about 0.11% of the company) valued at roughly $19.38 million at the end of the quarter; institutional investors own 95.44% of the stock.
• Tenet beat quarterly expectations with EPS $4.70 vs. $4.08 and revenue $5.53B vs. $5.47B, and provided FY2026 guidance of $16.19–$18.47 EPS.
• Analysts are broadly positive—MarketBeat shows a consensus rating of "Moderate Buy" with an average price target of $247.67, and several firms (Wells Fargo, RBC, Barclays, KeyCorp) have raised targets or issued overweight/outperform ratings.

Gabelli Funds LLC lowered its position in shares of Tenet Healthcare Corporation (NYSE:THC - Free Report) by 30.6% in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The fund owned 95,435 shares of the company's stock after selling 42,000 shares during the period. Gabelli Funds LLC owned about 0.11% of Tenet Healthcare worth $19,377,000 at the end of the most recent reporting period.

Other institutional investors have also recently modified their holdings of the company. William B. Walkup & Associates Inc. bought a new stake in Tenet Healthcare in the 3rd quarter worth approximately $32,000. Westside Investment Management Inc. grew its position in Tenet Healthcare by 100.0% during the third quarter. Westside Investment Management Inc. now owns 192 shares of the company's stock valued at $39,000 after acquiring an additional 96 shares during the last quarter. Trust Co. of Vermont purchased a new position in shares of Tenet Healthcare during the third quarter worth approximately $41,000. Canada Pension Plan Investment Board purchased a new stake in shares of Tenet Healthcare in the 2nd quarter valued at $35,000. Finally, True Wealth Design LLC grew its holdings in shares of Tenet Healthcare by 238.2% during the 2nd quarter. True Wealth Design LLC now owns 257 shares of the company's stock valued at $45,000 after purchasing an additional 181 shares during the last quarter. 95.44% of the stock is currently owned by institutional investors.

Analyst Upgrades and Downgrades

THC has been the subject of several recent research reports. Wells Fargo & Company reissued an "overweight" rating and issued a $265.00 price target on shares of Tenet Healthcare in a research note on Monday, February 16th. KeyCorp lifted their price objective on Tenet Healthcare from $225.00 to $250.00 and gave the stock an "overweight" rating in a report on Thursday, February 12th. Barclays increased their target price on Tenet Healthcare from $240.00 to $257.00 and gave the company an "overweight" rating in a report on Friday, February 13th. TD Cowen restated a "buy" rating on shares of Tenet Healthcare in a research report on Thursday, February 12th. Finally, Royal Bank Of Canada boosted their price objective on Tenet Healthcare from $253.00 to $277.00 and gave the company an "outperform" rating in a research report on Thursday, February 12th. One analyst has rated the stock with a Strong Buy rating, eighteen have given a Buy rating and three have issued a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and an average price target of $247.67.

Tenet Healthcare Stock Performance

Tenet Healthcare stock opened at $236.67 on Friday. Tenet Healthcare Corporation has a 1-year low of $109.82 and a 1-year high of $247.21. The firm has a market cap of $20.58 billion, a P/E ratio of 15.28, a P/E/G ratio of 1.17 and a beta of 1.39. The company has a current ratio of 1.76, a quick ratio of 1.68 and a debt-to-equity ratio of 2.18. The firm has a 50-day moving average of $210.13 and a 200-day moving average of $202.29.

Tenet Healthcare (NYSE:THC - Get Free Report) last released its quarterly earnings results on Wednesday, February 11th. The company reported $4.70 EPS for the quarter, beating analysts' consensus estimates of $4.08 by $0.62. The business had revenue of $5.53 billion during the quarter, compared to analyst estimates of $5.47 billion. Tenet Healthcare had a return on equity of 26.33% and a net margin of 6.60%.Tenet Healthcare's quarterly revenue was up 8.9% compared to the same quarter last year. During the same quarter in the prior year, the company posted $3.44 EPS. Tenet Healthcare has set its FY 2026 guidance at 16.190-18.470 EPS. Sell-side analysts expect that Tenet Healthcare Corporation will post 12.24 EPS for the current year.

Insider Buying and Selling

In other news, EVP Thomas W. Arnst sold 24,000 shares of the firm's stock in a transaction dated Monday, March 2nd. The shares were sold at an average price of $234.04, for a total value of $5,616,960.00. Following the completion of the sale, the executive vice president directly owned 8,012 shares of the company's stock, valued at approximately $1,875,128.48. This trade represents a 74.97% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. Also, Director Nadja West sold 2,178 shares of the business's stock in a transaction dated Monday, December 15th. The shares were sold at an average price of $197.47, for a total transaction of $430,089.66. Following the transaction, the director owned 28,480 shares in the company, valued at $5,623,945.60. This represents a 7.10% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 34,195 shares of company stock valued at $7,912,606 over the last quarter. 0.81% of the stock is owned by company insiders.

About Tenet Healthcare

Tenet Healthcare Corporation NYSE: THC is a diversified American healthcare services company that owns and operates acute care hospitals and a broad range of outpatient facilities. Its portfolio includes general acute-care hospitals, specialty hospitals, ambulatory surgery centers, urgent care and diagnostic imaging centers, and other ancillary service locations. Tenet's operations are oriented around delivering inpatient and outpatient clinical care across multiple medical specialties, with an emphasis on surgical services, emergency care, and advanced diagnostics.

In addition to facility-based care, Tenet provides integrated services designed to support clinical operations and improve patient access and care coordination.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.